BIOGENESIS LABORATORY Trademark

Trademark Overview


On Monday, May 13, 2024, a trademark application was filed for BIOGENESIS LABORATORY with the United States Patent and Trademark Office. The USPTO has given the BIOGENESIS LABORATORY trademark a serial number of 98547402. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, November 27, 2024. This trademark is owned by BioGenesis Laboratory LLC. The BIOGENESIS LABORATORY trademark is filed in the Pharmaceutical Products category with the following description:

Dietary supplements

General Information


Serial Number98547402
Word MarkBIOGENESIS LABORATORY
Filing DateMonday, May 13, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, November 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesDietary supplements

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, May 13, 2024
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBioGenesis Laboratory LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDover, OH 44622

Trademark Events


Event DateEvent Description
Monday, May 13, 2024NEW APPLICATION ENTERED
Monday, May 13, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 26, 2024ASSIGNED TO EXAMINER
Wednesday, November 27, 2024NON-FINAL ACTION WRITTEN
Wednesday, November 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, November 27, 2024NON-FINAL ACTION E-MAILED